BNET Industries

  • Public
  • US
Dow Jones Description

The Company, a Utah Corporation, was incorporated on March 21, 1981. Since incorporation the Company has undergone several name, ownership, directional and management changes. In July, 1998 the Company changed its name to E-Commerce West Corp. from Royal Casino Group reflecting a shift in its primary business focus from gaming to e-Commerce. The Company changed its name to IBNG in 2001 and then changed its name to Baymark Technologies, Inc. in 2002, concurrent with a 1 for 6 reverse split of its common stock. The Company has no revenues or business operations. The Company stock traded on the OTCBB and on the "Pink Sheets" under the symbol "BYMT" in the fiscal year after fiscal year end, and after September 30, 2005, the Company symbol was changed to "BYMR" on the OTCBB. The Company maintains its principal office at 7609 Ralston Road, Arvada, CO 80002. The Company's mailing address is 7609 Ralston Road, Arvada, CO 80002, it's telephone and fax numbers are (303) 422.8127.

President, Chief Executive Officer
George W Rozakis
Contact Information

17101 Preston Road #210

Dallas, Texas 75248

implantablevisi...

214-687-0015

NAICS Code Medical Laboratories: 621511

Decision Makers

Name (plus bio) Position
George W Rozakis President, Chief Executive Officer
Igor Valyunin Chief Scientific Officer
William Rozakis Chief Financial Officer and Secretary
Alexander Hatsis Medical Director

Board of Directors

Name (plus bio) Position
Jerry Kaeni Board of Directors

Organization Position Status
Implantable Vision, Inc. President, Chief Executive Officer Current

Igor Valyunin Dr. Valyunin was Chief Biopolymer Engineer at the Dr. Federov Eye Institute (MNTK) in Moscow, Russia and a key member of the group that invented phakic refractive lenses in the 1980's. He has over 20 years of experience in developing and manufacturing the lenses and has developed and patented in conjunction with Dr. Rozakis, the design of our lens. In 1997, he held the patent on the PRL phakic lens that was licensed by International Vision, Inc. The company transferred the technology to the United States and subsequently acquired Medennium, Inc., a California manufacturing facility. The lens utilized international data to bypass Phase I FDA studies and is currently in FDA Phase III trials. The marketing rights were licensed to CIBA Novartis in the United States, and Zeiss Inc. internationally. Since that time, Igor developed a new generation of lenses, including product line extensions, to be commercialized by our company, Implantable Vision, Inc. He received his degree from the Leningrad Technology Institute in Russia with a specialization in Chemistry, technology of organic synthesis. He also remained at the university and received an MBA equivalent degree.

Organization Position Status
Implantable Vision, Inc. Chief Scientific Officer Current

Organization Position Status
Implantable Vision, Inc. Chief Financial Officer and Secretary Current
Vision Sensors, LLC Current
Duke University Degree In Biomedical Engineering Former

Organization Position Status
The State University of New York Director of Refractive Surgery Current
Implantable Vision, Inc. Medical Director Current
The State University of New York Assistant Clinical Professor Current
Implantable Vision, Inc. Board of Directors Current
American Academy of Ophthalmology, Inc. Board of Directors Current
American College of Surgeons Fellow Current
American Academy of Ophthalmology, Inc. Member Current
Fordham University Bachelors of Science Degree In Biology Former

Organization Position Status
Millennium Biomedical, Inc Chief Executive Officer Current
Millennium Biomedical, Inc President Current
Implantable Vision, Inc. Board of Directors Current
ESCO Corporation Engineering Manager Former
Iolab Corporation Former
advertisement
advertisement
Click Here